50 results
Page 2 of 3
8-K
EX-10.1
z6sqsl
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
424B3
4am45u
14 Jan 22
Prospectus supplement
5:18pm
8-K
EX-10.1
bp6mb9isn14bo10aen
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
424B5
ga9lfx w5nhb
23 Dec 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-10.1
limr3l hx7uhln3cj5w
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
424B5
4l4nnlqgyty7p
1 Dec 21
Prospectus supplement for primary offering
5:10pm
8-K
EX-10.1
y74ns
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
93k6q z0v
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-K
EX-10.1
t9toer4t
31 Mar 21
Annual report
4:30pm
10-K
EX-10.9
efwd3m0 m8dyjfhkly
31 Mar 21
Annual report
4:30pm
10-K
obau0
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
gi8fw0w5j
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
nd1saa03
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.3
gomafadd 12ephndfm
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.4
q7llytl5iqikfpt3gper
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-10.1
t7yqoz
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.2
y3vg9hh u9ep
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-10.1
chhfp4j
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
fhcdx3
2 Nov 20
Prospectus supplement
12:00am